• Back to miR-100-5p

• Denk J, Boelmans K, Siegismund C, Lassner D, Arlt S, Jahn H. MicroRNAProfiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease. PLoSOne. 2015 May 20;10(5):e0126423. doi: 10.1371/journal.pone.0126423. eCollection2015. PubMed PMID: 25992776; PubMed Central PMCID: PMC4439119. See more on PubMed
• Hromadnikova I, Kotlabova K, Dvorakova L, Krofta L. Postpartum profiling ofmicroRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications. Int J Cardiol. 2019 Sep15;291:158-167. doi: 10.1016/j.ijcard.2019.05.036. Epub 2019 May 21. PubMed PMID:31151766. See more on PubMed
• Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H. A Panel of MicroRNA Signature as a Tool for Predicting Survival ofPatients with Urothelial Carcinoma of the Bladder. Dis Markers. 2018 Jun20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018. PubMed PMID:30026881; PubMed Central PMCID: PMC6031086. See more on PubMed
• Jakob M, Mattes LM, Küffer S, Unger K, Hess J, Bertlich M, Haubner F, Ihler F,Canis M, Weiss BG, Kitz J. MicroRNA expression patterns in oral squamous cellcarcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oralcancer. Head Neck. 2019 Oct;41(10):3499-3515. doi: 10.1002/hed.25866. Epub 2019Jul 29. PubMed PMID: 31355988. See more on PubMed
• Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB,Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, ChangJPE, Tan CK, Lee CGL. Circulating microRNAs as Potential Diagnostic andPrognostic Biomarkers in Hepatocellular Carcinoma. Sci Rep. 2019 Jul18;9(1):10464. doi: 10.1038/s41598-019-46872-8. PubMed PMID: 31320713; PubMedCentral PMCID: PMC6639394. See more on PubMed
• Li C, Gao Y, Zhang K, Chen J, Han S, Feng B, Wang R, Chen L. Multiple Roles ofMicroRNA-100 in Human Cancer and its Therapeutic Potential. Cell Physiol Biochem.2015;37(6):2143-59. doi: 10.1159/000438572. Epub 2015 Nov 26. Review. PubMedPMID: 26606597. See more on PubMed
• Luan Y, Zhang S, Zuo L, Zhou L. Overexpression of miR-100 inhibits cellproliferation, migration, and chemosensitivity in human glioblastoma throughFGFR3. Onco Targets Ther. 2015 Nov 17;8:3391-400. doi: 10.2147/OTT.S85677.eCollection 2015. PubMed PMID: 26604796; PubMed Central PMCID: PMC4655956. See more on PubMed
• Luo J, Chen B, Ji XX, Zhou SW, Zheng D. Overexpression of miR-100 inhibitscancer growth, migration, and chemosensitivity in human NSCLC cells throughfibroblast growth factor receptor 3. Tumour Biol. 2015 Aug 28. [Epub ahead ofprint] PubMed PMID: 26314855. See more on PubMed
• Qin X, Yu S, Zhou L, Shi M, Hu Y, Xu X, Shen B, Liu S, Yan D, Feng J.Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatinresistance of recipient cells in exosomal miR-100-5p-dependent manner. Int JNanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection2017. PubMed PMID: 28553110; PubMed Central PMCID: PMC5439933. See more on PubMed
• Song SK, Jung WY, Park SK, Chung CW, Park Y. Significantly differentexpression levels of microRNAs associated with vascular invasion inhepatocellular carcinoma and their prognostic significance after surgicalresection. PLoS One. 2019 Sep 12;14(9):e0216847. doi:10.1371/journal.pone.0216847. eCollection 2019. PubMed PMID: 31513595; PubMedCentral PMCID: PMC6742465. See more on PubMed
• Zhang B, Zhao R, He Y, Fu X, Fu L, Zhu Z, Fu L, Dong JT. MicroRNA 100sensitizes luminal A breast cancer cells to paclitaxel treatment in part bytargeting mTOR. Oncotarget. 2016 Feb 2;7(5):5702-14. doi:10.18632/oncotarget.6790. PubMed PMID: 26744318; PubMed Central PMCID:PMC4868715. See more on PubMed